Victrex (OTCMKTS:VTXPF) Trading Down 6.2%

Victrex plc (OTCMKTS:VTXPF) shares dropped 6.2% on Monday . The company traded as low as $17.67 and last traded at $17.67. Approximately 318 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 576 shares. The stock had previously closed at $18.84.

Wall Street Analysts Forecast Growth

Several research firms have commented on VTXPF. Jefferies Financial Group decreased their price objective on shares of Victrex from GBX 1,900 ($23.54) to GBX 1,590 ($19.70) in a research note on Monday, May 22nd. Berenberg Bank upgraded shares of Victrex from a “hold” rating to a “buy” rating in a research note on Monday, July 17th. Barclays decreased their price objective on shares of Victrex from GBX 2,090 ($25.89) to GBX 1,880 ($23.29) in a research note on Tuesday, July 18th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Victrex from GBX 2,050 ($25.39) to GBX 1,750 ($21.68) in a research note on Thursday, June 15th.

Victrex Stock Down 6.2 %

The company’s 50 day moving average price is $18.65 and its 200-day moving average price is $19.46. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.60 and a current ratio of 3.37.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.